These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 34746639)

  • 1. Paradoxical cardiac conduction during exercise stress testing in myotonic dystrophy type 1: a case report.
    Ahmad S; Kabunga P
    Eur Heart J Case Rep; 2021 Nov; 5(11):ytab409. PubMed ID: 34746639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Normal Electrocardiogram Does Not Exclude Infra-Hisian Conduction Disease in Patients With Myotonic Dystrophy Type 1.
    Creta A; Providência R; Gossios T; Elliott PM; Turner C; Savvatis K; Segal OR
    JACC Clin Electrophysiol; 2021 Aug; 7(8):1038-1048. PubMed ID: 33812832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evolution of infrahissian conduction time in myotonic dystrophy patients: clinical implications.
    Lallemand B; Clementy N; Bernard-Brunet A; Pierre B; Corcia P; Fauchier L; Raynaud M; Pellieux S; Babuty D
    Heart; 2012 Feb; 98(4):291-6. PubMed ID: 22038543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrocardiographic predictors of infrahissian conduction disturbances in myotonic dystrophy type 1.
    Joosten IBT; van Lohuizen R; den Uijl DW; Evertz R; de Greef BTA; van Engelen BGM; Faber CG; Vernooy K
    Europace; 2021 Feb; 23(2):298-304. PubMed ID: 33150426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of type 1 Brugada ECG pattern after administration of Class 1C drugs in patients with type 1 myotonic dystrophy: Myotonic dystrophy as a part of the Brugada syndrome.
    Maury P; Audoubert M; Cintas P; Rollin A; Duparc A; Mondoly P; Chiriac AM; Acket B; Zhao X; Pasquié JL; Cardin C; Delay M; Sadron M; Carrié D; Galinier M; Davy JM; Arne-Bès MC; Raczka F
    Heart Rhythm; 2014 Oct; 11(10):1721-7. PubMed ID: 25016148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial fibrosis by late gadolinium enhancement cardiovascular magnetic resonance in myotonic muscular dystrophy type 1: highly prevalent but not associated with surface conduction abnormality.
    Cardona A; Arnold WD; Kissel JT; Raman SV; Zareba KM
    J Cardiovasc Magn Reson; 2019 May; 21(1):26. PubMed ID: 31046780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Management of atrioventricular conduction abnormalities in myotonic dystrophy].
    Tamura T
    Rinsho Shinkeigaku; 2012; 52(11):1261-3. PubMed ID: 23196583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is it possible to identify infrahissian cardiac conduction abnormalities in myotonic dystrophy by non-invasive methods?
    Babuty D; Fauchier L; Tena-Carbi D; Poret P; Leche J; Raynaud M; Fauchier JP; Cosnay P
    Heart; 1999 Nov; 82(5):634-7. PubMed ID: 10525524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-invasive evaluation of the relationship between electrical and structural cardiac abnormalities in patients with myotonic dystrophy type 1.
    Chmielewski L; Bietenbeck M; Patrascu A; Rösch S; Sechtem U; Yilmaz A; Florian AR
    Clin Res Cardiol; 2019 Aug; 108(8):857-867. PubMed ID: 30767060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ajmaline Challenge To Unmask Infrahisian Disease In Patients With Recurrent And Unexplained Syncope, Preserved Ejection Fraction, With Or Without Conduction Abnormalities On Surface ECG.
    Pentimalli F; Bacino L; Ghione M; Giambattista S; Gazzarata M; Bellotti P
    J Atr Fibrillation; 2016; 9(2):1421. PubMed ID: 27909532
    [No Abstract]   [Full Text] [Related]  

  • 11. Biventricular pacing (cardiac resynchronization therapy): an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(13):1-60. PubMed ID: 23074464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cardiac, respiratory and sleep disorders in patients with myotonic dystrophy].
    Banach M; Rakowicz M; Antczak J; Rola R; Witkowski G; Waliniowska E
    Przegl Lek; 2009; 66(12):1065-8. PubMed ID: 20514907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and functional cardiac changes in myotonic dystrophy type 1: a cardiovascular magnetic resonance study.
    Hermans MC; Faber CG; Bekkers SC; de Die-Smulders CE; Gerrits MM; Merkies IS; Snoep G; Pinto YM; Schalla S
    J Cardiovasc Magn Reson; 2012 Jul; 14(1):48. PubMed ID: 22827830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indications for Cardiac Pacemaker Implantation in Myotonic Dystrophy.
    Hawley RJ; Colleran JA; Fletcher R; Verdino RJ; Kokkinos P; Pinnow E
    MedGenMed; 1999 Sep; ():E5. PubMed ID: 11104407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [When do you implant a pacemaker in myotonic dystrophy?].
    Babuty D; Lallemand B; Laurent V; Clémenty N; Pierre B; Fauchier L; Raynaud M; Pellieux S
    Presse Med; 2011; 40(7-8):748-53. PubMed ID: 21549556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships among electrophysiological findings and clinical status, heart function, and extent of DNA mutation in myotonic dystrophy.
    Lazarus A; Varin J; Ounnoughene Z; Radvanyi H; Junien C; Coste J; Laforet P; Eymard B; Becane HM; Weber S; Duboc D
    Circulation; 1999 Mar; 99(8):1041-6. PubMed ID: 10051298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients: P wave duration and dispersion analysis.
    Russo V; Di Meo F; Rago A; Papa AA; Molino A; Mosella M; Politano L; Russo MG; Nigro G
    Eur Rev Med Pharmacol Sci; 2015 Apr; 19(7):1241-8. PubMed ID: 25912584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of atrio-ventricular conduction disease, long-term outcomes in patients with myotonic dystrophy types I and II.
    Ha AH; Tarnopolsky MA; Bergstra TG; Nair GM; Al-Qubbany A; Healey JS
    Pacing Clin Electrophysiol; 2012 Oct; 35(10):1262-9. PubMed ID: 22385162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of cardiac conduction system abnormalities in mice with targeted disruption of Six5 gene.
    Wakimoto H; Maguire CT; Sherwood MC; Vargas MM; Sarkar PS; Han J; Reddy S; Berul CI
    J Interv Card Electrophysiol; 2002 Oct; 7(2):127-35. PubMed ID: 12397222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac involvement in myotonic muscular dystrophy.
    Moorman JR; Coleman RE; Packer DL; Kisslo JA; Bell J; Hettleman BD; Stajich J; Roses AD
    Medicine (Baltimore); 1985 Nov; 64(6):371-87. PubMed ID: 4058303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.